6.31
price up icon1.45%   0.09
after-market アフターアワーズ: 6.31
loading
前日終値:
$6.22
開ける:
$6.295
24時間の取引高:
2.09M
Relative Volume:
0.42
時価総額:
$1.94B
収益:
$493.67M
当期純損益:
$-104.69M
株価収益率:
-18.56
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
+3.95%
1か月 パフォーマンス:
+10.51%
6か月 パフォーマンス:
-34.61%
1年 パフォーマンス:
-38.80%
1日の値動き範囲:
Value
$6.275
$6.37
1週間の範囲:
Value
$5.915
$6.77
52週間の値動き範囲:
Value
$5.51
$12.65

Amicus Therapeutics Inc Stock (FOLD) Company Profile

Name
名前
Amicus Therapeutics Inc
Name
セクター
Healthcare (1163)
Name
電話
(609) 662-2000
Name
住所
47 HULFISH STREET, PRINCETON, NJ
Name
職員
499
Name
Twitter
@amicusrx1
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
FOLD's Discussions on Twitter

FOLD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FOLD
Amicus Therapeutics Inc
6.31 1.92B 493.67M -104.69M -31.51M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-13 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-09-06 開始されました Jefferies Buy
2024-05-30 開始されました Wells Fargo Overweight
2024-05-14 アップグレード Guggenheim Neutral → Buy
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-09-09 開始されました Morgan Stanley Equal-Weight
2022-04-13 再開されました Goldman Neutral
2022-01-14 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-15 アップグレード Stifel Hold → Buy
2021-09-30 アップグレード JP Morgan Neutral → Overweight
2021-07-19 再開されました BTIG Research Buy
2021-05-27 開始されました Needham Hold
2021-05-21 開始されました UBS Buy
2021-04-14 アップグレード Cantor Fitzgerald Neutral → Overweight
2021-03-02 開始されました Stifel Hold
2021-02-12 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-02-12 ダウングレード JP Morgan Overweight → Neutral
2020-12-28 再開されました Cantor Fitzgerald Overweight
2020-12-10 ダウングレード Citigroup Buy → Neutral
2020-11-11 開始されました Berenberg Hold
2020-06-17 開始されました BTIG Research Buy
2020-02-04 再開されました Cantor Fitzgerald Overweight
2019-11-12 繰り返されました H.C. Wainwright Buy
2019-06-17 開始されました H.C. Wainwright Buy
2019-06-05 繰り返されました Cantor Fitzgerald Overweight
2019-04-05 開始されました Janney Buy
2019-01-30 開始されました Cantor Fitzgerald Overweight
2018-10-29 開始されました Citigroup Neutral
2018-08-17 ダウングレード Chardan Capital Markets Buy → Neutral
2017-10-06 再開されました Goldman Neutral
2017-09-13 繰り返されました Chardan Capital Markets Buy
2017-08-10 繰り返されました Chardan Capital Markets Buy
2017-01-24 アップグレード Robert W. Baird Neutral → Outperform
2016-05-18 開始されました BofA/Merrill Buy
2016-04-14 開始されました Robert W. Baird Neutral
2016-04-12 繰り返されました Chardan Capital Markets Buy
2015-09-16 ダウングレード Chardan Capital Markets Buy → Neutral
2015-06-16 繰り返されました Chardan Capital Markets Buy
すべてを表示

Amicus Therapeutics Inc (FOLD) 最新ニュース

pulisher
Jul 23, 2025

What drives Amicus Therapeutics Inc. stock priceExceptional profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Amicus Therapeutics Inc. Stock Analysis and ForecastFree Technical Analysis Support - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Edgestream Partners L.P. Makes New Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Amicus Therapeutics Inc. stockSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-23 00:04:03 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Amicus Therapeutics Sets Date for Q2 Earnings: Key Updates Expected from Rare Disease Pipeline - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Stock Rating Upgraded by Morgan Stanley - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Is Amicus Therapeutics Inc. a good long term investmentRemarkable growth - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap UpWhat's Next? - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Amicus (FOLD) Gets Japan Approval for Pombiliti + Opfolda - MSN

Jul 19, 2025
pulisher
Jul 17, 2025

Amicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switching - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Amicus stock gains as Morgan Stanley upgrades (FOLD:NASDAQ) - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

Amicus Therapeutics: A Biotech Buy with Legal, Product, and Market Catalysts - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Amicus Therapeutics (FOLD) Soars 10.05% on Japan Approval - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Rice Hall James & Associates LLC Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Amicus Therapeutics stock upgraded to Overweight by Morgan Stanley on IP strength - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Stephens Investment Management Group LLC Makes New $5 Million Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 17, 2025
pulisher
Jul 16, 2025

10 Best Small-Cap Stocks to Buy According to Billionaires - Insider Monkey

Jul 16, 2025
pulisher
Jul 14, 2025

Q2 EPS Estimate for Amicus Therapeutics Increased by Analyst - MarketBeat

Jul 14, 2025
pulisher
Jul 13, 2025

Zacks Research Issues Optimistic Forecast for FOLD Earnings - MarketBeat

Jul 13, 2025
pulisher
Jul 13, 2025

Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $16.22 - MarketBeat

Jul 13, 2025
pulisher
Jul 12, 2025

Amicus Therapeutics (FOLD): Securing Rare Disease Dominance Through Strategic Deals and Pipeline Momentum - AInvest

Jul 12, 2025
pulisher
Jul 12, 2025

TD Cowen Remains Bullish on Amicus Therapeutics (FOLD) With a $20 PT - Yahoo Finance

Jul 12, 2025
pulisher
Jul 10, 2025

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm - Longview News-Journal

Jul 10, 2025

Amicus Therapeutics Inc (FOLD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
大文字化:     |  ボリューム (24 時間):